Página 1 a partir de 40 resultados
This invention relates to a new therapeutic use for lysine p-isobutylphenylpropionate.
More particularly, the invention relates to the anti-inflammatory use of lysine p-isobutylphenylpropionate in topical gynecological therapy.
Lysine p-isobutylphenylpropionate, also called hereinafter by its
The object of the present invention relates to a topical pharmaceutical composition in the form of foam containing as active ingredient a compound having antiinflammatory activity which belongs to the class of the arylpropionic acids.
More particularly the arylpropionic acid contained in the
FIELD OF THE INVENTION
The present invention relates to peptides comprising lysine, alanine, leucine and valine, pharmaceutical compositions comprising same, and uses thereof for treating inflammatory conditions and allergy.
BACKGROUND OF THE INVENTION
Antimicrobial Peptides
Lipopolysaccharides
This application is a U.S. national phase application under 35 U.S.C. .sctn.371 of International Application No. PCT/EP2013/056145, filed Mar. 22, 2013, which claims priority to German Application No. DE 20 2012103733.5, filed Sep. 28, 2012, the disclosures of which is hereby incorporated by
BACKGROUND OF THE INVENTION
Certain phenyl-alkanoic acids are known from the literature and some of them are said to possess valuable pharmacological activities, for example, an analgesic, anti-inflammatory or anti-pyretic action, whereas others are used clinically, for example, in the treatment of
FIELD OF INVENTION
The present invention relates to substances and compositions for the prevention and treatment of diseases or pathological states related to the degradation of the extracellular matrix, such as including but not limited to degenerative diseases, particularly arteriosclerosis,
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention relates to a new pharmaceutical composition useful for the treatment of pyrexia and inflammation. More particularly, this invention relates to a tripeptide sequence contained in alpha-Melanocyte Stimulating Hormone and ACTH which
1. FIELD OF THE INVENTION
This invention relates to a new pharmaceutical composition useful for the treatment of pyrexia and inflammation. More particularly, this invention relates to a tripeptide sequence contained in alpha-Melanocyte Stimulating Hormone and ACTH which has been identified as an
FIELD OF THE INVENTION
This invention concerns a new family of peptide molecules having the capacity especially of stimulating the expression of the cytokines of inflammation and promoting regeneration of tissues. The invention, thus, also pertains to pharmaceutical compositions containing at least
TECHNICAL FIELD
The present invention relates to the treatment of wounds in animals in general, and more specifically, to the use of a peptide having human superoxide dismutase activity, glycyl-L-hystidyl-L-lysine: copper(II), for enhancing the wound-healing process.
BACKGROUND ART
Mechanisms of
The present invention relates to a class of compounds useful in the diagnosis of sites of venous and arterial thrombosis, embolism or infection, pharmaceutical formulations containing them, their use in the diagnosis of disease and methods for their preparation.
Prior approaches to thrombus imaging
FIELD OF THE INVENTION
This invention relates to pharmaceutical compositions of the d,l- or l-lysine salt of R,S or S-ibuprofen having analgesic, anti-inflammatory and anti-pyretic activity. The invention further relates to a method of treating pain or inflammation or of reducing fever by
A preferred embodiment of this drug is further characterized by a proportion of vitamin A and/or vitamin B.sub.12 and/or folic acid.
Another preferred embodiment of the drug as provided by the invention is characterized by a proportion of vitamin A and/or thymine (=a pyrimidine base).
The drug in
TECHNICAL FIELD
The present invention relates to an agent for treating or preventing an inflammatory bowel disease, comprising a particular amino acid(s). The present invention also relates to an agent for inhibiting TNF production, comprising a particular amino acid(s).
BACKGROUND ART
An
INCORPORATION BY REFERENCE OF MATERIAL IN ASCII TEXT FILE
This application incorporates by reference the Sequence Listing contained in the following ASCII text file being submitted concurrently herewith:
a) File name: TDQ-10021_SEQLISTING.txt; created Feb. 1, 2018, 28 KB in size.
BACKGROUND OF THE